The NYU Kaplan Comprehensive Cancer Center is an interdisciplinary and interdepartmental program designed to foster, enhance and coordinate the conduct of oncology research, education and patient care activity at NYU Medical Center. Gaining comprehensive status in 1991 and merging with the cancer center of the Institute of Environmental Medicine in 1992, the Center now represents the total spectrum of the institution's cancer activities. Its membership consists of NYU medical school faculty actively engaged in cancer research at all levels of investigation. The Center promotes through its program orientation and specialized shared resource units, the collaboration and technology transfer intended to more rapidly translate the benefits of research into more effective approaches to cancer. A broad range of oncology research is being conducted at the Center through nine program units and the support of seventeen shared resources. The Center places particular emphasis on elucidating the molecular and genetic events responsible for cellular transformation; the host defense mechanisms which regulate the immune response; the etiologic agents within the environment which cause or contribute to cancer; and the therapies and prevention which will prove to be more effective.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016087-20S4
Application #
2878890
Study Section
Cancer Center Support Review Committee (CCS)
Program Officer
Mccormick, Patricia
Project Start
1975-06-30
Project End
1998-11-30
Budget Start
1997-12-01
Budget End
1998-11-30
Support Year
20
Fiscal Year
1998
Total Cost
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Wong, Serre-Yu; Coffre, Maryaline; Ramanan, Deepshika et al. (2018) B Cell Defects Observed in Nod2 Knockout Mice Are a Consequence of a Dock2 Mutation Frequently Found in Inbred Strains. J Immunol 201:1442-1451
Burgess, Hannah M; Pourchet, Aldo; Hajdu, Cristina H et al. (2018) Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus. Mol Ther Oncolytics 8:71-81
Diamond, Julie M; Vanpouille-Box, Claire; Spada, Sheila et al. (2018) Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs. Cancer Immunol Res 6:910-920
Handler, Jesse; Cullis, Jane; Avanzi, Antonina et al. (2018) Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-? exposure. Oncogene 37:4334-4342
Chen, Danqi; Fang, Lei; Mei, Shenglin et al. (2018) Erratum: ""Regulation of Chromatin Assembly and Cell Transformation by Formaldehyde Exposure in Human Cells"". Environ Health Perspect 126:019001
Fan, Xiaozhou; Peters, Brandilyn A; Jacobs, Eric J et al. (2018) Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome 6:59
Wadghiri, Youssef Z; Hoang, Dung Minh; Leporati, Anita et al. (2018) High-resolution Imaging of Myeloperoxidase Activity Sensors in Human Cerebrovascular Disease. Sci Rep 8:7687
Khodadadi-Jamayran, Alireza; Akgol-Oksuz, Betul; Afanasyeva, Yelena et al. (2018) Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process. Oncotarget 9:12868-12878
Wang, Shiyang; Liechty, Benjamin; Patel, Seema et al. (2018) Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors. J Neurooncol 138:183-190
Nancy, Patrice; Siewiera, Johan; Rizzuto, Gabrielle et al. (2018) H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. J Clin Invest 128:233-247

Showing the most recent 10 out of 1170 publications